Episode 4: Interview with Dave Rosa Part 2

In our final episode for this series, we bring back our first guest, Dave Rosa, to continue our conversation on NeuroOne technologies looking into the future. Dave introduces a number of exciting new technologies, such as needle-sized electrodes and an electrode combine two procedures into one. All these new technologies are being developed with the aim of reducing invasiveness and patient trauma. Dave mentions the cooperative and parallel development of software along with hardware, and how AI-based technology is an exciting thing to look forward to.

Our third episode of Behind the Electrodes introduces Dr. Douglas Weber, professor of Mechanical Engineering at the Neuroscience Institute of Carnegie Mellon University and founding member of DARPA's Biological Technologies Office. From his experience, Dr. Weber notes the surprising difference between the technology used in research compared to the technology used in practice. He also emphasizes the importance of using AI systems to process data from the thousands of channels in brain. Dr. Weber closes with some optimistic projections about more flexible and adaptable neuroscience devices that can allow communication on many different levels.

In our second episode, we have Dr. Kip Ludwig, who leads the Bioelectronic Medicines Laboratory at the University of Wisconsin, as well as serving on the NeuroOne Medical Technologies advisory board and as the chairman of the AI advisory board. Dr. Ludwig talks through the difficulty with collecting data from information channels and how a certain type of electrode may be capable of triggering a reconnection to lost senses.

In the inaugural episode of Behind the Electrodes: Stimulating conversations, we interview Dave Rosa, CEO of NeuroOne Technologies. Dave talks about the decisions he made to end up at NeuroOne, and also describes just what makes NeuroOne electrodes stand out against competitors.